488 related articles for article (PubMed ID: 27356019)
1. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
[TBL] [Abstract][Full Text] [Related]
2. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.
Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ofek P; Tiram G; Kalinski H; Avkin-Nachum S; Feiner Gracia N; Albertazzi L; Satchi-Fainaro R
Nanomedicine; 2018 Feb; 14(2):303-315. PubMed ID: 29127036
[TBL] [Abstract][Full Text] [Related]
3. Structure-Function Correlation of Aminated Poly(α)glutamate as siRNA Nanocarriers.
Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ori A; Avkin-Nachum S; Krivitsky V; Satchi-Fainaro R
Biomacromolecules; 2016 Sep; 17(9):2787-800. PubMed ID: 27377188
[TBL] [Abstract][Full Text] [Related]
4. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
[TBL] [Abstract][Full Text] [Related]
5. Highly stable polyglutamate derivatives/siRNA polyplex efficiently down-relegate survivin expression and augment the efficacy of cisplatin.
Wang Z; Zou H; Wang Z; Wu J; Xia Z; Feng M
Int J Pharm; 2016 May; 505(1-2):24-34. PubMed ID: 27039150
[TBL] [Abstract][Full Text] [Related]
6. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
[TBL] [Abstract][Full Text] [Related]
7. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
[TBL] [Abstract][Full Text] [Related]
8. Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers.
Krivitsky A; Krivitsky V; Polyak D; Scomparin A; Eliyahu S; Gibori H; Yeini E; Pisarevsky E; Blau R; Satchi-Fainaro R
Polymers (Basel); 2018 May; 10(5):. PubMed ID: 30966582
[TBL] [Abstract][Full Text] [Related]
9. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
[TBL] [Abstract][Full Text] [Related]
10. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
11. Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA.
Beloor J; Choi CS; Nam HY; Park M; Kim SH; Jackson A; Lee KY; Kim SW; Kumar P; Lee SK
Biomaterials; 2012 Feb; 33(5):1640-50. PubMed ID: 22112761
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.
Lu S; Morris VB; Labhasetwar V
J Pharmacol Exp Ther; 2019 Sep; 370(3):902-910. PubMed ID: 30940690
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
15. Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting.
Yoon HY; Kim HR; Saravanakumar G; Heo R; Chae SY; Um W; Kim K; Kwon IC; Lee JY; Lee DS; Park JC; Park JH
J Control Release; 2013 Dec; 172(3):653-61. PubMed ID: 24055507
[TBL] [Abstract][Full Text] [Related]
16. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy.
Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC
Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428
[TBL] [Abstract][Full Text] [Related]
17. An injectable cell penetrable nano-polyplex hydrogel for localized siRNA delivery.
Kim YM; Park MR; Song SC
Biomaterials; 2013 Jun; 34(18):4493-500. PubMed ID: 23498897
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
[TBL] [Abstract][Full Text] [Related]
19. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
[TBL] [Abstract][Full Text] [Related]
20. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]